📂 Drugs
ieramilimab — Definition
İeramilimab / ieramilimab
Ieramilimab is a monochlonal antibody belonging to the immunocontrol point inhibitors class. The target is LAG-3 (Lymphocyte Activation Gene-3) protein that suppresses the activation of immune cells. This drug was developed specifically for use in the treatment of advanced stage melanom and other solid tumors, strengthening T cell response to cancer cells. In clinical studies, the event is investigated in combination with other immunotherapy.
Frequently Asked Questions
❓ What is İeramilimab?
İeramilimab; ieramilimab is a monochlonal antibody belonging to the immunocontrol point inhibitors class. The target is LAG-3 (Lymphocyte Activation Gene-3) protein that suppresses the activation of immune cells. This drug was developed specifically for use in the treatment of advanced stage melanom and other solid tumors, strengthening T cell response to cancer cells. In clinical studies, the event is investigated in combination with other immunotherapy.
❓ What is ieramilimab in Turkish?
The Turkish equivalent of "ieramilimab" is İeramilimab.
❓ Which medical field is İeramilimab related to?
This term belongs to the Drugs category.